ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Livzon Pharmaceutical Group, Inc. ?
1
High Debt company with Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -0.28% and Operating profit at 2.72% over the last 5 years
- The company is Net-Debt Free
2
Positive results in Dec 16
- PRE-TAX PROFIT(Q) At HKD 565.61 MM has Grown at inf%
- ROCE(HY) Highest at 14.74%
- RAW MATERIAL COST(Y) Fallen by -4.49% (YoY)
3
With ROE of 15.58%, it has a Fair valuation with a 0.43 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -30.17%, its profits have fallen by -1.1% ; the PEG ratio of the company is 2.1
4
Below par performance in long term as well as near term
- Along with generating -30.17% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Livzon Pharmaceutical Group, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Livzon Pharmaceutical Group, Inc. for you?
Medium Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Livzon Pharmaceutical Group, Inc.
-30.17%
-0.12
31.32%
Hang Seng Hong Kong
0.26%
0.01
20.12%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-0.28%
EBIT Growth (5y)
2.72%
EBIT to Interest (avg)
28.22
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
0.70
Tax Ratio
15.70%
Dividend Payout Ratio
66.87%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
28.92%
ROE (avg)
15.50%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
3
Industry P/E
Price to Book Value
0.43
EV to EBIT
0.19
EV to EBITDA
0.16
EV to Capital Employed
0.05
EV to Sales
0.04
PEG Ratio
2.08
Dividend Yield
NA
ROCE (Latest)
28.14%
ROE (Latest)
15.58%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Livzon Pharmaceutical Group, Inc.
Pre-Tax Profit
At HKD 565.61 MM has Grown at inf%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (HKD MM)
Debtors Turnover Ratio
Highest at 4.08 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -4.49% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
